BOSENTAS 62.5

Description

BOSENTAS 62.5 contains Bosentan, a dual endothelin receptor antagonist used in the treatment of Pulmonary Arterial Hypertension (PAH). It works by blocking the action of endothelin-1, a substance that causes narrowing of blood vessels, thereby relaxing pulmonary arteries, lowering blood pressure in the lungs, and improving the ability to exercise. BOSENTAS helps slow the progression of PAH and enhances overall cardiovascular performance and quality of life.

This medication is suitable for patients in WHO functional class II and III PAH, including those with idiopathic or congenital causes. When taken as prescribed, BOSENTAS 62.5 improves oxygen delivery, reduces strain on the heart, and increases physical stamina in daily activities. Regular monitoring of liver function and hemoglobin levels is essential during therapy to ensure optimal results and safety.